Physician profile
Brian J Johnson
NPI 1487151288
$4,367.87
in general payments reported to CMS, 2019-2025
17 companies · $2,069 in 2025
The $2,069 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $386 · 2024: $1,913 · 2025: $2,069.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,057 · Education: $311.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,057.37 |
| Education | $310.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,415.40 | 2023-2025 | |
| Teva Pharmaceuticals USA, INC. | $959.48 | 2024-2025 | Austedo Xr, Austedo Xr |
| Lundbeck LLC | $491.43 | 2023-2025 | Vyepti |
| Pfizer INC. | $399.05 | 2023-2025 | |
| Ucb, INC. | $262.66 | 2023-2025 | Briviact, Zilbrysq, Nayzilam |
| Eisai INC. | $185.61 | 2024-2025 | |
| Boston Scientific Corporation | $174.42 | 2024 | Watchman Access System |
| Lilly USA, LLC | $125.50 | 2024-2025 | Kisunla, Reyvow, Emgality |
| Argenx US, INC. | $85.22 | 2025 | Vyvgart Hytrulo |
| Sumitomo Pharma America, INC. | $79.90 | 2023 | Aptiom |
| Sk Life Science, INC. | $70.43 | 2025 | |
| Amneal Pharmaceuticals LLC | $25.56 | 2025 | Crexont |
| Kyowa Kirin, INC. | $25.05 | 2023 | Nourianz |
| Grifols USA, LLC | $21.08 | 2024 | Gamunex-C |
| Cala Health, INC. | $19.18 | 2024 | Cala Kiq, Cala Trio |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $16.40 | 2023 | Ultomiris |
| Corium, LLC | $11.50 | 2023 | Adlarity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.